Cargando…
DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma
Gastric cancer (GC) is the second most widespread cause of cancer-related mortality worldwide. The discovery of novel biomarkers of oncoproteins can facilitate the development of therapeutic strategies for GC treatment. In this study, we identified novel biomarkers by integrating isobaric tags for r...
Autores principales: | Lee, Kam-Fai, Tsai, Ming-Ming, Tsai, Chung-Ying, Huang, Chung-Guei, Ou, Yu-Hsiang, Hsieh, Ching-Chuan, Hsieh, Hsi-Lung, Wang, Chia-Siu, Lin, Kwang-Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888682/ https://www.ncbi.nlm.nih.gov/pubmed/31766266 http://dx.doi.org/10.3390/ijms20225689 |
Ejemplares similares
-
MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer
por: Tsai, Ming-Ming, et al.
Publicado: (2016) -
Tumor progression-dependent angiogenesis in gastric cancer and its potential application
por: Hsieh, Hsi-Lung, et al.
Publicado: (2019) -
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer
por: Tsai, Ming-Ming, et al.
Publicado: (2016) -
Molecular mechanism of therapeutic approaches for human gastric cancer stem cells
por: Hsieh, Hsi-Lung, et al.
Publicado: (2022) -
DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
por: Yang, Mai-Qing, et al.
Publicado: (2021)